Avantor, Inc.

AVTR Healthcare Medical Instruments & Supplies

Avantor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.6 billion, down 3.41% from fiscal 2024.

Revenue
+4.59%
EPS
+128.9%
Free cash flow
−9.03%
Total debt
−4.51%

Quarter to September 2026, against a year earlier

15.14 0.51 −3.26%
Market cap
$10.3B
P/E
30.3×
Fwd P/E
34.8×
Dividend yield
—
F-score
4/9
Altman Z
1.55
Beneish M
−2.91
Dividend safety
n/a
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
P/E ratio
30.10 0.00 0.00 0.00

+8 more quarters

P/S ratio
1.54 1.02 0.81 1.19
P/FCF ratio
23.20 14.72 12.07 15.76
P/Operating CF
52.23 37.57 90.25 51.08
P/B ratio
1.75 1.19 0.95 1.40
EV/Sales
2.02 1.54 1.35 1.74
EV/EBITDA
14.68 80.81 68.22 65.97
EV/FCF
30.53 22.18 20.13 22.99
Current Ratio
1.89 1.78 1.76 1.78
Net Debt/EBITDA
13.06 14.80 17.14 15.46
Debt/Equity
0.63 0.66 0.68 0.71
Earnings Yield
3.32% (8.48%) (10.33%) (6.81%)
Free Cash Flow Yield
4.31% 6.79% 8.29% 6.35%
Free Cash Flow per Share
0.23 0.21 0.04 0.17
Book value per Share
8.62 8.33 8.27 8.18
Free Cash Flow
156.20 140.60 25.20 117.20
EV/EBIT
27.52 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026